Avidity Biosciences (RNA) PT Raised to $62 at Barclays
Tweet
Share
E-mailGet Alerts RNA Hot Sheet
Price: $13.98 --0%
Rating Summary:
12 Buy, 11 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 2 | New: 2
Rating Summary:
12 Buy, 11 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 2 | New: 2
Join SI Premium – FREE
Barclays analyst Gena Wang raised the price target on Avidity Biosciences (NASDAQ: RNA) to $62.00 (from $59.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Citi Upgrades Domino's Pizza Enterprises Ltd. (DMP:AU) (DPZUF) to Buy
- Worley Ltd (WOR:AU) (WYGPY) PT Lowered to AUD12 at Citi
- Sawai Group Holdings Co., Ltd (4887:JP) (SWPIF) PT Lowered to JPY2,100 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
